Here's What Key Metrics Tell Us About Aflac (AFL) Q2 Earnings
Werte in diesem Artikel
For the quarter ended June 2025, Aflac (AFL) reported revenue of $4.54 billion, down 11.7% over the same period last year. EPS came in at $1.78, compared to $1.83 in the year-ago quarter.The reported revenue represents a surprise of +2.3% over the Zacks Consensus Estimate of $4.43 billion. With the consensus EPS estimate being $1.71, the EPS surprise was +4.09%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Aflac performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total Benefit /Premium - Aflac Japan: 66.5% compared to the 65.3% average estimate based on three analysts.Total Adjusted Expenses/Total Adjusted Revenue - Aflac U.S.: 36.3% compared to the 38.1% average estimate based on three analysts.Total Benefit /Premium - Aflac U.S.: 47.3% versus the three-analyst average estimate of 47.8%.Total Adjusted Expenses/Total Adjusted Revenue - Aflac Japan: 20.6% versus 19.7% estimated by three analysts on average.Total adjusted revenues- Aflac U.S.: $1.73 billion versus $1.74 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +2.6% change.Total adjusted revenues- Aflac Japan: $2.47 billion versus the three-analyst average estimate of $2.38 billion. The reported number represents a year-over-year change of +1%.Total adjusted revenues- Aflac U.S.- Total net earned premiums: $1.5 billion versus $1.52 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +3.4% change.Total adjusted revenues- Aflac Japan- Other income: $12 million versus $6.67 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +71.4% change.Revenues- Other income (loss): $30 million versus the five-analyst average estimate of $29.8 million. The reported number represents a year-over-year change of +36.4%.Revenues- Net investment income: $1.08 billion versus $907.26 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -1.3% change.Revenues- Total net earned premiums: $3.47 billion versus the five-analyst average estimate of $3.44 billion. The reported number represents a year-over-year change of +4.4%.Total adjusted revenues- Corporate and other: $336 million compared to the $328.5 million average estimate based on two analysts. The reported number represents a change of +34.9% year over year.View all Key Company Metrics for Aflac here>>>Shares of Aflac have returned -4.2% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Aflac und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Aflac
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Aflac Inc
Analysen zu Aflac Inc
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2018 | Aflac Equal Weight | Barclays Capital | |
03.07.2017 | Aflac Equal Weight | Barclays Capital | |
01.05.2017 | Aflac Underperform | RBC Capital Markets | |
02.02.2017 | Aflac Underperform | RBC Capital Markets | |
09.12.2016 | Aflac Underperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.05.2012 | Aflac outperform | RBC Capital Markets | |
14.05.2012 | Aflac overweight | Barclays Capital | |
27.04.2012 | Aflac sector outperform | Scotia Capital Markets | |
26.04.2012 | Aflac outperform | RBC Capital Markets | |
27.03.2012 | Aflac overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2018 | Aflac Equal Weight | Barclays Capital | |
03.07.2017 | Aflac Equal Weight | Barclays Capital | |
10.05.2016 | Aflac Mkt Perform | FBR Capital | |
27.04.2016 | Aflac Neutral | UBS AG | |
27.04.2016 | Aflac Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2017 | Aflac Underperform | RBC Capital Markets | |
02.02.2017 | Aflac Underperform | RBC Capital Markets | |
09.12.2016 | Aflac Underperform | RBC Capital Markets | |
09.01.2012 | Aflac sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen